Development of Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD Models to Determine Dosimetry and Cholinesterase Inhibition Following Exposure to Binary Mixtures of Organophosphorus Insecticides
-
2007/03/01
Details
-
Personal Author:
-
Description:PBPK/PD models have been developed for the organophosphorus (OP) insecticides chlorpyrifos (CPF) and diazinon (DZN). These insecticides share common metabolic activation/detoxification pathways and a common mechanism of neurotoxicity associated with excessive cholinergic stimulation. To develop a binary OP PBPK/PD model, rats were orally administered CPF, DZN or a CPF/DZN mixture (0, 15, 30 or 60 mg/kg) and blood (plasma and RBC), brain and urine were collected for analysis. Chlorpyrifos, DZN and their respective metabolites, trichloropyridinol and isopropy-methyl-hydroxypyrimidine were quantified in blood and/or urine and cholinesterase (ChE) inhibition was measured in brain, RBC, and plasma. Co-exposure to CPF/DZN at the low dose (15/15 mg/kg) did not alter the pharmacokinetics of CPF, DZN or their metabolites in blood. Whereas, a high binary dose (60/60 mg/kg) increased the Cmax and AUC and decreased the clearance for both parent compounds, likely due to competition between CPF and DZN for CYP450 metabolism. At lower doses the pharmacokinetics appeared linear. A dose-dependent inhibition of ChE was noted in tissues for both the single and co-exposures, and the extent of inhibition was plasma > RBC > or equal to brain. The overall relative potency for ChE inhibition was CPF > CPF/DZN > DZN. A comparison of the ChE response at the low binary dose (15/15 mg/kg), where there were no apparent pharmacokinetic interactions, suggested that the overall ChE response was additive. Based on these pharmacokinetic results a binary OP PBPK/PD model has been developed. This model facilitates understanding the mixture interactions and the potential for additivity, synergism or antagonism from multi-OP exposures. It is envisioned that this binary model will be useful for accessing exposure and health risk to a wide range of exposed individuals. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:96
-
Issue:1
-
NIOSHTIC Number:nn:20031925
-
Citation:Toxicologist 2007 Mar; 96(1):274
-
CAS Registry Number:
-
Federal Fiscal Year:2007
-
NORA Priority Area:
-
Performing Organization:Battelle Memorial Institute, Richland, Washington
-
Peer Reviewed:False
-
Start Date:20010930
-
Source Full Name:The Toxicologist. Society of Toxicology 46th Annual Meeting and ToxExpo, March 25-29, 2007, Charlotte, North Carolina
-
End Date:20050929
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d4cf25b6677ebc4eb069f72cb4b79d66cd1a2918f32894c12fe65686e37f26437030d895ad3d5800fa1886672562717afa5b8fe17192ce134f89d78a6d09ad55
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like